Hunan Hansen Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
119,532.50
100,299.00
85,021.30
108,806.30
147,536.80
Depreciation, Depletion & Amortization
-
36,031.90
39,763.10
42,370.80
44,601.40
46,253.70
Other Funds
1,026.70
-
1,657.30
2,280.30
14,674.50
9,714.70
Funds from Operations
108,196.80
156,441.30
144,471.80
135,679.70
164,232.30
182,850.20
Changes in Working Capital
-
63,767.30
74,031.10
36,557.20
46,200.70
41,637.70
Net Operating Cash Flow
108,196.80
92,674.00
70,440.70
172,236.90
118,031.60
224,487.90
Capital Expenditures
108,440.10
73,751.60
75,889.70
44,910.60
50,198.00
Sale of Fixed Assets & Businesses
46.60
100.70
113.60
3.30
43.90
Purchase/Sale of Investments
274,099.30
8,000.00
34,940.00
415,900.00
-
Net Investing Cash Flow
57,507.20
65,650.90
110,716.20
540,807.30
50,154.10
Cash Dividends Paid - Total
-
74,000.00
-
-
148,000.00
Issuance/Reduction of Debt, Net
30,000.00
-
31,637.80
278,297.80
58,300.00
Net Financing Cash Flow
31,026.70
74,000.00
33,295.10
276,017.40
104,374.50
Net Change in Cash
134,677.40
46,976.90
73,570.60
92,552.90
36,497.00
Free Cash Flow
243.30
18,922.40
5,449.00
127,326.30
67,833.60
Deferred Taxes & Investment Tax Credit
-
1,505.40
772.30
1,604.90
400.50
1,225.70
Net Assets from Acquisitions
-
-
-
80,000.00
-
Other Sources
440,000.00
-
-
-
-
About Hunan Hansen Pharmaceutical Co.
View Profile
